Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System

Part of paid clinical trials in Portland, Oregon.

Sponsor
Oregon Health and Science University
Study ID
NCT04900298
Status
Recruiting
Apply to this trial

Conditions

  • Cross Infection
  • Surgical Wound Infection

Eligibility Criteria

Sex
ALL
Age
18 Years - 99 Years
Healthy Volunteers
Not accepted

Interventions

  • SafeHaven Automated Hand Hygiene Device — DEVICE
    Anesthesia providers in the intervention arm will be given a personal hand hygiene device, containing 64% ethyl alcohol, which provides actionable real-time performance feedback. The personalized device will be affixed to the provider's waist and will remain there for use throughout the perioperative period. Performance feedback is given to the anesthesia provider in real time with the number of personal hand hygiene events and an hourly hand hygiene rate, which is displayed on the device. Devices will be handed out to participating providers in the preoperative bay and retrieved in the post-anesthesia care unit upon case completion.

Study Details

The investigators hypothesize that the use of a personal hand hygiene system (SafeHavenTM) by anesthesia providers in the adult operating room, combined with a novel infectious pathogen tracking system (OR PathTrac) will decrease participant exposure to pathologic bacteria in the adult operating room.

Key Dates

Start date
Jan 1, 2022
Status verified
Jun 2024
Primary completion
Dec 31, 2025
Completion
Jun 30, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION

Arms

  • Experimental: Intervention Arm
    Use of SafeHaven hand hygiene system in the operating room
  • No Intervention: Control Arm
    Standard of care hand hygiene

Primary Outcome Measure

Number of ESKAPE (Enterococcus, S. Aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) reservoirs identified using microbial culture collection kits [ Time Frame: Perioperative Time, typically less than 12 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Oregon Health and Science UniversityPortlandOregon97239
Brandon M Togioka, MD
[email protected]
503-494-4572
Sarah Feller
[email protected]
Brandon M Togioka, MD (PRINCIPAL_INVESTIGATOR)
Sydney Rose, MD (SUB_INVESTIGATOR)

Find similar trials in Portland, OR

By research site
Oregon Health and Science University· Portland, OR

Related Studies